A manually curated ChIP-seq benchmark demonstrates room for improvement in current peak-finder programs.

Morten Beck Rye1, Pål Sætrom, Finn Drabløs

  • 1Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, NO-7489 Trondheim, Norway. morten.rye@ntnu.no

Nucleic Acids Research
|November 30, 2010
PubMed
Summary

Chromatin immunoprecipitation sequencing (ChIP-seq) peak calling programs often produce false positives. Manual inspection and improved peak definitions are essential for accurate transcription factor binding site identification.